trial
as of 2026-07-01Rt-fMRI Neurofeedback and AH in Schizophrenia
NCTId NCT03504579
at a glance
— · Completed
Enrollment 25 (actual)
Sponsored by Harvard Medical School (HMS and HSDM)
Primary completion 2022-03-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
25 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2018-03-01
Primary completion
2022-03-30
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Harvard Medical School (HMS and HSDM)Lead Sponsor
Investigators
2
Margaret McNamara McClure, Ph.D.Principal Investigator
susan whitfield-Gabrieli, Ph.D.Principal Investigator
Sites
1 total
Brockton, United States
Facts & assertions
4 sourced
Enrollment
25
Phase
NA
Primary Completion Date
2022-03-30
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator